Safety and upscaling of remote consulting for long-term conditions in primary health care in Nigeria and Tanzania (REaCH trials): stepped-wedge trials of training, mobile data allowance, and implementation.


Journal

The Lancet. Global health
ISSN: 2214-109X
Titre abrégé: Lancet Glob Health
Pays: England
ID NLM: 101613665

Informations de publication

Date de publication:
11 2023
Historique:
received: 21 03 2023
revised: 15 08 2023
accepted: 21 08 2023
medline: 23 10 2023
pubmed: 20 10 2023
entrez: 20 10 2023
Statut: ppublish

Résumé

In-person health care poses risks to health workers and patients during pandemics. Remote consultations can mitigate these risks. The REaCH intervention comprised training and mobile data allowance provision for mobile phones to support remotely delivered primary care in Africa compared with no training and mobile data allowance. The aim of this study was to estimate the effects of REaCH among adults with non-communicable diseases on remote and face-to-face consultation rates, patient safety, and trustworthiness of consultations. In these two independent stepped-wedge cluster randomised controlled trials, we enrolled 20 primary care clusters in each of two settings (Oyo State, Nigeria, and Morogoro Region, Tanzania). Eligible clusters had 100 or more patients with diabetes, hypertension, and cardiovascular or pulmonary disease employing five health workers. Clusters were computer-randomised to one of ten (Nigeria) or one of seven (Tanzania) sequences to receive the REaCH intervention. Only outcome assessors were masked. Primary outcomes were consultation, prescription, and investigation rates, and trustworthiness collected monthly for 12 months (Nigeria) and 9 months (Tanzania) from open cohorts. Ten randomly sampled consulting patients per cluster-month completed patient reported outcome measures. This trial was registered with ISRCTN, ISRCTN17941313. Overall, 40 clusters comprising 8776 (Nigeria) and 3246 (Tanzania) patients' open cohort data were analysed (6377 [72·7%] of 8776 females in Nigeria, and 2235 [68·9%] of 3246 females in Tanzania). The mean age of the participants was 55·3 years (SD 13·9) in Nigeria and 59·2 years (14·2) in Tanzania. In Nigeria, no evidence of change in face-to-face consulting rate was observed (rate ratio [RR] 1·06, 95% CI 0·98 to 1·09; p=0·16); however, remote consultations increased four-fold (4·44, 1·34 to >10; p=0·01). In Tanzania, face-to-face (0·94, 0·61 to 1·67; p=0·99) and remote consulting rates (1·17, 0·56 to 5·57; p=0·39) were unchanged. There was no evidence of difference in prescribing rates (Nigeria: 1·05, 0·60 to 1·14; p=0·23; Tanzania: 0·92, 0·60 to 1·67; p=0·97), investigation rates (Nigeria: 1·06, 0·23 to 2·12; p=0·49; Tanzania: 1·15, 0·35 to 1·64; 0·58) or trustworthiness scores (Nigeria: mean difference 0·05, 95% CI -0·45 to 0·42; p=0·89; Tanzania: 0·07, -0·15 to 0·76; p=0·70). REaCH can be implemented and could improve intervention versus control health-care access. Remote consultations appear safe and trustworthy, supporting universal health coverage. The UK Research and Innovation Collective Fund. For the Swahili and Yoruba translations of the abstract see Supplementary Materials section.

Sections du résumé

BACKGROUND
In-person health care poses risks to health workers and patients during pandemics. Remote consultations can mitigate these risks. The REaCH intervention comprised training and mobile data allowance provision for mobile phones to support remotely delivered primary care in Africa compared with no training and mobile data allowance. The aim of this study was to estimate the effects of REaCH among adults with non-communicable diseases on remote and face-to-face consultation rates, patient safety, and trustworthiness of consultations.
METHODS
In these two independent stepped-wedge cluster randomised controlled trials, we enrolled 20 primary care clusters in each of two settings (Oyo State, Nigeria, and Morogoro Region, Tanzania). Eligible clusters had 100 or more patients with diabetes, hypertension, and cardiovascular or pulmonary disease employing five health workers. Clusters were computer-randomised to one of ten (Nigeria) or one of seven (Tanzania) sequences to receive the REaCH intervention. Only outcome assessors were masked. Primary outcomes were consultation, prescription, and investigation rates, and trustworthiness collected monthly for 12 months (Nigeria) and 9 months (Tanzania) from open cohorts. Ten randomly sampled consulting patients per cluster-month completed patient reported outcome measures. This trial was registered with ISRCTN, ISRCTN17941313.
FINDINGS
Overall, 40 clusters comprising 8776 (Nigeria) and 3246 (Tanzania) patients' open cohort data were analysed (6377 [72·7%] of 8776 females in Nigeria, and 2235 [68·9%] of 3246 females in Tanzania). The mean age of the participants was 55·3 years (SD 13·9) in Nigeria and 59·2 years (14·2) in Tanzania. In Nigeria, no evidence of change in face-to-face consulting rate was observed (rate ratio [RR] 1·06, 95% CI 0·98 to 1·09; p=0·16); however, remote consultations increased four-fold (4·44, 1·34 to >10; p=0·01). In Tanzania, face-to-face (0·94, 0·61 to 1·67; p=0·99) and remote consulting rates (1·17, 0·56 to 5·57; p=0·39) were unchanged. There was no evidence of difference in prescribing rates (Nigeria: 1·05, 0·60 to 1·14; p=0·23; Tanzania: 0·92, 0·60 to 1·67; p=0·97), investigation rates (Nigeria: 1·06, 0·23 to 2·12; p=0·49; Tanzania: 1·15, 0·35 to 1·64; 0·58) or trustworthiness scores (Nigeria: mean difference 0·05, 95% CI -0·45 to 0·42; p=0·89; Tanzania: 0·07, -0·15 to 0·76; p=0·70).
INTERPRETATION
REaCH can be implemented and could improve intervention versus control health-care access. Remote consultations appear safe and trustworthy, supporting universal health coverage.
FUNDING
The UK Research and Innovation Collective Fund.
TRANSLATIONS
For the Swahili and Yoruba translations of the abstract see Supplementary Materials section.

Identifiants

pubmed: 37858586
pii: S2214-109X(23)00411-4
doi: 10.1016/S2214-109X(23)00411-4
pii:
doi:

Banques de données

ISRCTN
['ISRCTN17941313']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1753-e1764

Subventions

Organisme : Department of Health
Pays : United Kingdom

Investigateurs

Jackie Sturt (J)
Akinyinka Omigbodun (A)
Andrew Downie (A)
Beatrice Chipwaza (B)
Jonathan Cave (J)
Eme Owoaje (E)
Eniola Olubukola Cadmus (EO)
Emmanuel Adebayo (E)
Rebecca Rogers (R)
Frances Griffiths (F)
Richard Harding (R)
Bronwyn Harris (B)
Albino Kalolo (A)
Motunrayo Ajisola (M)
Helen Muir (H)
Kennedy Nkhoma (K)
Joshua Odunayo Akinyemi (JO)
Olufunke Fayehun (O)
Richard Lilford (R)
Samuel I Watson (SI)
Senga Pemba (S)
Sylvester Ndegese (S)
Vincent Kiberu (V)
Titus Mashanya (T)
David Ayobami Adewole (DA)
Meleji Losyeku (M)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests RH has leadership or fiduciary roles as follows: Trustee at Marie Curie; co-chair of the African Palliative Care Association Research Network; member of the British HIV Association Standards steering committee; and Vice-Chair of the Worldwide Hospice Palliative Care Alliance. SIW has received standard research grants from The National Institute for Health and Care Research, Medical Research Council, and The National Institute of Mental Health (USA) as either principal and co-investigator. All other authors have no competing interests.

Auteurs

Jackie Sturt (J)

Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK. Electronic address: jackie.sturt@kcl.ac.uk.

Frances Griffiths (F)

Warwick Medical School, University of Warwick, Coventry, UK; Centre for Health Policy, University of the Witwatersrand, Johannesburg, South Africa.

Motunrayo Ajisola (M)

College of Medicine, University of Ibadan Nigeria, Ibadan, Nigeria.

Joshua Odunayo Akinyemi (JO)

College of Medicine, University of Ibadan Nigeria, Ibadan, Nigeria; Department of Epidemiology and Medical Statistics, University of Ibadan Nigeria, Ibadan, Nigeria.

Beatrice Chipwaza (B)

School of Medicine, St Francis University College of Health and Allied Sciences, Ifakara, Tanzania.

Olufunke Fayehun (O)

Department of Sociology, University of Ibadan Nigeria, Ibadan, Nigeria.

Bronwyn Harris (B)

Warwick Medical School, University of Warwick, Coventry, UK.

Eme Owoaje (E)

Department of Community Medicine, University of Ibadan Nigeria, Ibadan, Nigeria.

Rebecca Rogers (R)

Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK.

Senga Pemba (S)

School of Medicine, St Francis University College of Health and Allied Sciences, Ifakara, Tanzania.

Samuel I Watson (SI)

Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

Akinyinka Omigbodun (A)

College of Medicine, University of Ibadan Nigeria, Ibadan, Nigeria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH